Skip to main content
Caplight Logo









Alfaleus Technology

Alfaleus Technology

Private
JaipurHealthcare & Life Scienceshttps://alfaleus.in/

Last Round

Grant

May 29, 2024

Total Funding Raised

$300,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Alfaleus Technology is a health tech company that develops virtual reality-based eye care technology, including portable visual field perimeters for glaucoma screening and low vision assistive aids.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, AR/VR Hardware, Telemedicine

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

visual field perimeterperimetryglaucoma screeningVR medical deviceportable eye carelow vision aidtelemedicineophthalmology equipmentdigital healtheye diagnostic toolhealthtechmedtechautomated screeninggaze tracking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alfaleus Technology Comparables

Compare Alfaleus Technology with similar companies based on industry and business-model similarity.

Alfaleus Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elisar Vision Technology
94%
Oculera Health
87%
RadiusXR
86%

Alfaleus Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 29, 2024
SeedOct 18, 2021
SeedFeb 1, 2019

Key People

Founding team and executive leadership

Sandal Kotawala

Chief Executive Officer

Executive Team

Alfaleus Technology Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2026

    Grew 67% QoQ, from 12 to 20 employees.

  • Jul 27, 2026

    Grew 91% QoQ, from 11 to 21 employees.

Alfaleus Technology Filings

Explore SEC and related filing metadata, where available.

Alfaleus Technology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alfaleus Technology's valuation, stock price, and market status.

Is Alfaleus Technology a public or private company?

Alfaleus Technology is a private company.

What is the current stock price of Alfaleus Technology?

Alfaleus Technology is a private company, so its shares have no public market price. Caplight tracks Alfaleus Technology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Alfaleus Technology worth (valuation)?

Valuation information for Alfaleus Technology is not publicly available.

Can I buy Alfaleus Technology stock?

Alfaleus Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Alfaleus Technology's last funding round?

Alfaleus Technology's most recent funding round was Grant on May 29, 2024.

Who are the main investors in Alfaleus Technology?

Key investors in Alfaleus Technology include Biotechnology Industry Research Assistance Council, VIT-Technology Business Incubator, Government of India.

Will Alfaleus Technology IPO soon?

No public IPO plans have been announced for Alfaleus Technology.

How can I track Alfaleus Technology secondary market activity?

Caplight tracks bids, offers, and trades in Alfaleus Technology's shares on secondary markets.

Firmographic Details

HeadquartersJaipur
Employee Range16
Year Founded2018
Last FundingMay 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?